Paul Wang to GABA-B Receptor Agonists
This is a "connection" page, showing publications Paul Wang has written about GABA-B Receptor Agonists.
Connection Strength
0.235
-
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial. Neuropsychopharmacology. 2017 Jun; 42(7):1390-1398.
Score: 0.128
-
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014 Apr; 44(4):958-64.
Score: 0.107